Bill
SF 205
Antineoplastic cancer treatment prior authorization prohibition
2025-2026 Regular Session
Introduced by Liz Boldon and 3 co-sponsors
Prohibits insurers from requiring prior authorization before covering cancer drug treatments, enabling faster patient access but removing cost-control review mechanisms.
Comm report: To pass as amended and re-refer to Health and Human Services